These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2465301)

  • 41. Impact of neuropeptide substance P an inflammatory compound on arachidonic acid compound generation.
    Nicoletti M; Neri G; Maccauro G; Tripodi D; Varvara G; Saggini A; Potalivo G; Castellani ML; Fulcheri M; Rosati M; Toniato E; Caraffa A; Antinolfi P; Cerulli G; Pandolfi F; Galzio R; Conti P; Theoharides TC
    Int J Immunopathol Pharmacol; 2012; 25(4):849-57. PubMed ID: 23298476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of a potent agonist of substance P by modifying the methionyl and glutaminyl residues of the C-terminal hexapeptide of substance P. Structure-activity relationships.
    Karagiannis K; Manolopoulou A; Stavropoulos G; Poulos C; Jordan CC; Hagan RM
    Int J Pept Protein Res; 1991 Oct; 38(4):350-6. PubMed ID: 1724664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuro-endocrine interaction on lymphocytes. Testosterone-induced modulation of the lymphocyte substance P receptor.
    Parnet P; Payan DG; Kerdelhué B; Mitsuhashi M
    J Neuroimmunol; 1990 Jul; 28(2):185-8. PubMed ID: 1694535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Letter: HL-A antigens and hypersensitivity to brain tissue in multiple sclerosis.
    Finkelstein S; Walford RL; Myers LW; Ellison GW
    Lancet; 1974 Apr; 1(7860):736. PubMed ID: 4132456
    [No Abstract]   [Full Text] [Related]  

  • 45. Allergen-specific immunotherapy: update on immunological mechanisms.
    Alvaro M; Sancha J; Larramona H; Lucas JM; Mesa M; Tabar AI; Martinez-Cañavate A; ;
    Allergol Immunopathol (Madr); 2013; 41(4):265-72. PubMed ID: 23332741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Substance P and microcirculation during stress].
    Gorizontova MP; Shinkarenko VS; Chernukh AM
    Biull Eksp Biol Med; 1982 Sep; 94(9):15-8. PubMed ID: 6184093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypersensitivity based on the immunological reactions (immediate type--delayed type)].
    Goetze E
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):476-9. PubMed ID: 4255947
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypersensitivity.
    Turk JL
    Scott Med J; 1971 Jun; 16(6):273-9. PubMed ID: 4103763
    [No Abstract]   [Full Text] [Related]  

  • 49. Neuropeptide modulation of the immune response in gut associated lymphoid tissue.
    O'Dorisio MS
    Int J Neurosci; 1988 Jan; 38(1-2):189-98. PubMed ID: 2451649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons.
    Cheramy A; Michelot R; Leviel V; Nieoullon A; Glowinski J; Kerdelhue B
    Brain Res; 1978 Oct; 155(2):404-8. PubMed ID: 688024
    [No Abstract]   [Full Text] [Related]  

  • 51. Dysregulation of IgE responses and airway allergic inflammation in atopic individuals.
    Ricci M; Rossi O
    Clin Exp Allergy; 1990 Nov; 20(6):601-9. PubMed ID: 2083399
    [No Abstract]   [Full Text] [Related]  

  • 52. Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist.
    Hanson G; Alphs L; Pradhan S; Lovenberg W
    Neuropharmacology; 1981 Jun; 20(6):541-8. PubMed ID: 6165922
    [No Abstract]   [Full Text] [Related]  

  • 53. Substance P and Parkinson's disease: a causal relationship?
    Barker R
    J Theor Biol; 1986 Jun; 120(3):353-62. PubMed ID: 2431225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atopic allergy in relation to cell-mediated immunity.
    Björkstén B
    Clin Rev Allergy; 1984 May; 2(2):95-106. PubMed ID: 6375851
    [No Abstract]   [Full Text] [Related]  

  • 55. [Regulation of the tracheobronchial and lung vascular system: innervation and receptors].
    Kneussl M
    Wien Klin Wochenschr; 1986 Nov; 98(21):7013-25. PubMed ID: 2433839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of substance P, hemokinin and their receptor in governing mucosal inflammation and granulomatous responses.
    Weinstock JV
    Front Biosci; 2004 May; 9():1936-43. PubMed ID: 14977599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropeptide regulation of the expression of immediate hypersensitivity.
    Goetzl EJ; Chernov T; Renold F; Payan DG
    J Immunol; 1985 Aug; 135(2 Suppl):802s-805s. PubMed ID: 2409168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Definition of an allergen (immunobiology).
    McSherry C; Blumenthal MN
    Clin Allergy Immunol; 2008; 21():31-46. PubMed ID: 18828496
    [No Abstract]   [Full Text] [Related]  

  • 59. Characterization of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation.
    Stubbs CM; Waldron GJ; Connor HE; Feniuk W
    Br J Pharmacol; 1992 Apr; 105(4):875-80. PubMed ID: 1380374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospects of applying some scientific data obtained in the field of cellular and humoral immunity in allergic diseases. Prophylaxis and treatment.
    Szegli G; Dincă L; Neguţ E; Peligrad I; Dinu I; Olinescu A; Arion R
    Arch Roum Pathol Exp Microbiol; 1990; 49(1):5-16. PubMed ID: 2101202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.